- For some time, we have had an interim CFO (consultant) on reduced hours, but in line with the commercialization of the business and our increasing focus on operations and optimization, we need a permanent, full resource who can help transform the finance function from simply accounting focus to finance/business focus. We have continuously been looking for the right profile, and we are convinced that we have found that in Peter. He has the necessary broad experience in working with business processes throughout the finance function and I am sure that Peter's versatility will help at
- For several years, the key focus of my work has been the transformation of finance departments, where I have used my role in finance to actively create a strong foundation with a modern finance function by means of optimizing processes and digitalization. I have a proactive approach to my work and am at the same time driven by a strong desire to create results through motivating my colleagues' drive and commitment.
About
For more information, visit: www.dancann.com.
For further information, please contact:
E-mail: jkr@dancann.com
Website: www.dancann.com
Forward looking statement
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology.
Forward-looking statements are subject to several risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities.
Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this presentation are made as of the date of this presentation and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
https://news.cision.com/dancann-pharma/r/dancann-pharma-a-s-has-appointed-peter-sondergaard-as-new-fulltime-cfo,c3692394
https://mb.cision.com/Main/19875/3692394/1762965.pdf
(c) 2023 Cision. All rights reserved., source